Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv
BACKGROUND: Cardiomyopathy guidelines recommend routine screening of at-risk relatives with dilated cardiomyopathy (DCM). Titin-truncating variants are the most prevalent cause. However, the diagnostic yield of screening is low. Risk-based stratification could optimize screening intervals and resource allocation. This study aims to develop a safe, evidence-based gene-specific longitudinal screening algorithm for DCM development. METHODS: We included likely pathogenic/pathogenic titin-truncating variant relatives from 7 centers who underwent cardiac screening. Relatives were stratified based on their baseline clinical phenotype: genotype-positive/phenotype-negative (no left ventricular dysfunction and dilatation) or partial DCM (ie, fulfilling only 1 criterion). DCM development predictors were identified based on follow-up data. Risk profiles were established and used to develop a multistate model to create a longitudinal screening algorithm to safely and effectively monitor titin-truncating variant relatives. RESULTS: Among 413 relatives, follow-up data were available in 301 relatives (median follow-up 5.7 years), of whom 24.6% developed left ventricular dysfunction or dilatation and 17.3% developed DCM. In total, 16 relatives (5.3%) experienced a major adverse cardiac event after DCM diagnosis. Based on the identified risk factors, age ≥30 years, male sex, and partial DCM, 3 distinct profiles were established: (1) relatives with partial DCM, (2) females ≥30 years and males, and (3) female relatives <30 years. A screening algorithm was developed, recommending intervals of 1, 3, and 5 years, optimizing the balance between safety and effectiveness. CONCLUSIONS: An evidence-based genotype-specific longitudinal screening algorithm that integrates age, sex, and echocardiographic measurements may improve patient care and improve efficiency of clinical resource allocation.
Authors
- Job A.J. Verdonschot (ORCID: https://orcid.org/0000-0001-5549-1298)
- Alex Hørby Christensen (ORCID: https://orcid.org/0000-0002-6855-1496)
- Christoffer Rasmus Vissing (ORCID: https://orcid.org/0000-0002-0834-206X)
- Daria R. Kramarenko (ORCID: https://orcid.org/0000-0001-6427-2521)
- Renée Johnson (ORCID: https://orcid.org/0000-0002-8979-2096)
- Sophie L.V.M. Stroeks (ORCID: https://orcid.org/0000-0003-0965-6359)
- Gianfranco Sinagra (ORCID: https://orcid.org/0000-0003-2700-8478)
- Ahmad S. Amin (ORCID: https://orcid.org/0000-0002-1600-7907)
- Fernándo Domínguez (ORCID: https://orcid.org/0000-0001-8408-363X)
- Henning Bundgaard (ORCID: https://orcid.org/0000-0002-0563-7049)
- Max F.G.H.M. Venner (ORCID: https://orcid.org/0009-0001-2574-6672)
- Steven A. Muller (ORCID: https://orcid.org/0000-0002-2674-8709)
- Marco Merlo (ORCID: https://orcid.org/0000-0002-1022-3131)
- Matteo Dal Ferro (ORCID: https://orcid.org/0000-0002-2310-0448)
- Pablo García‐Pavía (ORCID: https://orcid.org/0000-0002-5470-2257)
- Diane Fatkin (ORCID: https://orcid.org/0000-0002-9010-9856)
- Eva Del Mestre (ORCID: https://orcid.org/0009-0001-5432-9288)
- Alessia Paldino (ORCID: https://orcid.org/0000-0002-5823-3777)
- Anneline S.J.M. te Riele (ORCID: https://orcid.org/0000-0002-4694-4790)
- Guilielmus H.J.M. Ellenbroek (ORCID: https://orcid.org/0000-0001-7659-7702)
- Nina J Beelen (ORCID: https://orcid.org/0009-0008-0605-4604)
- Clea González-Maniega (ORCID: https://orcid.org/0009-0003-7772-7726)
Institutions
- Utrecht University (NL)
- Maastricht University Medical Centre (NL)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- University Medical Center Utrecht (NL)
- UNSW Sydney (AU)
- Maastricht University (NL)
- St Vincent's Hospital Sydney (AU)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Netherlands Heart Institute (NL)
- ERN GUARD-Heart (NL)
- Amsterdam University Medical Centers (NL)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
Publication Details
- Journal
- Circulation Heart Failure
- Published
- 2026-09-21
- DOI
- https://doi.org/10.1161/circheartfailure.125.013822
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00